Technical Analysis for MGNX - MacroGenics, Inc.

Grade Last Price % Change Price Change
grade B 21.78 -2.02% -0.45
MGNX closed up 0.36 percent on Wednesday, February 20, 2019, on 1.14 times normal volume.

Earnings due: Feb 26

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical MGNX trend table...

Date Alert Name Type % Chg
Feb 20 Narrow Range Bar Range Contraction -2.02%
Feb 20 Wide Bands Range Expansion -2.02%
Feb 20 Up 3 Days in a Row Strength -2.02%
Feb 19 Narrow Range Bar Range Contraction -1.67%
Feb 19 Wide Bands Range Expansion -1.67%
Feb 15 Wide Bands Range Expansion -0.27%
Feb 14 180 Bullish Setup Bullish Swing Setup 3.13%
Feb 14 Calm After Storm Range Contraction 3.13%
Feb 14 Narrow Range Bar Range Contraction 3.13%
Feb 14 NR7 Range Contraction 3.13%

Older signals for MGNX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody technology platforms, which it believes improve the performance of monoclonal antibodies and antibody-derived molecules. The company creates both differentiated molecules that are directed to novel cancer targets, as well as "bio-betters," which are drugs designed to improve upon marketed medicines. The combination of MacroGenics' technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.
Medicine Biotechnology Biopharmaceutical Cancer Life Sciences Biology Immunology Treatment Of Cancer Antibodies Immune System Monoclonal Antibodies Autoimmune Diseases Antibody Technology Platforms Novel Cancer
Is MGNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.74
52 Week Low 9.87
Average Volume 1,380,282
200-Day Moving Average 19.008
50-Day Moving Average 14.6812
20-Day Moving Average 16.819
10-Day Moving Average 22.19
Average True Range 1.9305
ADX 36.15
+DI 49.3201
-DI 18.3866
Chandelier Exit (Long, 3 ATRs ) 26.5285
Chandelier Exit (Short, 3 ATRs ) 15.661499999999999
Upper Bollinger Band 27.7147
Lower Bollinger Band 5.9233
Percent B (%b) 0.75
BandWidth 129.564183
MACD Line 2.4585
MACD Signal Line 1.8871
MACD Histogram 0.5714
Fundamentals Value
Market Cap 818.02 Million
Num Shares 36.8 Million
EPS -4.19
Price-to-Earnings (P/E) Ratio -5.31
Price-to-Sales 56.93
Price-to-Book 2.96
PEG Ratio 0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.63
Resistance 3 (R3) 23.58 23.08 23.39
Resistance 2 (R2) 23.08 22.72 23.10 23.31
Resistance 1 (R1) 22.65 22.50 22.87 22.70 23.24
Pivot Point 22.15 22.15 22.25 22.17 22.15
Support 1 (S1) 21.72 21.79 21.94 21.77 21.22
Support 2 (S2) 21.22 21.57 21.24 21.15
Support 3 (S3) 20.79 21.22 21.07
Support 4 (S4) 20.84